This profile has not been claimed and data may not be accurate.
Founder161Current founder
93rd percentile
Investor20Current investor
64th percentile
Combined
Co-founder & CEO of Commure, a $6–7B healthcare OS built from YC S16 roots
Credibility
this founder typical founder (50th pct)
Traction · 95th percentile
- Commure (the company Tandon leads as CEO and co-founded via the Athelas merger) is valued at approximately $7 billion as of 2026.
- Commure has annual revenue of $100M, a strong public signal of profitability-scale operations.
- Athelas raised $130M total from Sequoia Capital, General Catalyst, YCombinator, and NVIDIA per SEC Form D and LinkedIn.
- Top YouTube video 'How He Turned a Blood Test Startup Into $7B OS for Healthcare' has ~31,885 views — meaningful thought-leadership reach.
Relationship Matrix
Most Like You
Most Complimentary
Founder score
- 99%Probability of being accurate (99%)Y Combinator S16 alum — Athelas was part of YC Summer 2016.
- 98%Probability of being accurate (98%)Current co-founder and CEO of Athelas, actively running the company he co-founded in 2016.
- 95%Probability of being accurate (95%)commure.com ranks #340,338 on the Majestic Million (global domain prominence).
- 95%Probability of being accurate (95%)Athelas raised $130M total from Sequoia Capital, General Catalyst, YCombinator, and NVIDIA per SEC Form D and LinkedIn.
- 95%Probability of being accurate (95%)5,545 LinkedIn followers — broad professional reach.
- 92%Probability of being accurate (92%)Named the youngest global Indian on the HSBC Hurun Global Indians List 2024 at age 27 — elite recognition for entrepreneurial achievement.
- 88%Probability of being accurate (88%)Commure (the company Tandon leads as CEO and co-founded via the Athelas merger) is valued at approximately $7 billion as of 2026.
- 88%Probability of being accurate (88%)Google Science Fair Finalist and Intel STS National Finalist — notable STEM competition recognition.
- 85%Probability of being accurate (85%)Athelas was co-founded with co-founders, confirming a co-founding team.
- 85%Probability of being accurate (85%)Featured in a dedicated profile on Sequoia Capital's founder stories page, a tier-1 outlet for startup founders.
- 80%Probability of being accurate (80%)Commure has annual revenue of $100M, a strong public signal of profitability-scale operations.
- 78%Probability of being accurate (78%)Top YouTube video 'How He Turned a Blood Test Startup Into $7B OS for Healthcare' has ~31,885 views — meaningful thought-leadership reach.
- 65%Probability of being accurate (65%)Identified as a Hugging Face author (@tanaytandon), signaling active ML/AI model publishing.
Investor score
- 85%Probability of being accurate (85%)Publicly identified as an angel investor with confirmed investments including OneSchema and Clinikally.
- 80%Probability of being accurate (80%)Has made at least 2 confirmed angel investments (OneSchema, Clinikally).
- 55%Probability of being accurate (55%)Investing activity traceable to approximately 2019–2020, giving roughly 5–6 years of angel investing experience.
What you likely need
You're one of the most prominent young founders in health tech, running a $7B company built from a YC S16 seed. Your next leverage points are IPO readiness, scaling your executive team, and deepening your network among late-stage health tech operators and crossover investors. Events that connect you with other unicorn-stage founders navigating the public-markets path and with top healthcare system buyers would be highest-value.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingA YC S16/S17 unicorn-founder dinner for warm intros to crossover funds and late-stage health tech investors ahead of a potential IPO.
- tacticalA closed-door roundtable with other health tech CEOs (Athelas, Commure, Innovaccer, Abridge peers) on navigating hospital enterprise sales at scale.
- introsA Sequoia portfolio founder dinner to pressure-test Commure's go-to-market strategy with other Sequoia-backed health and SaaS founders.
- positioningAn IPO-readiness workshop with founders who have recently taken health tech companies public, focused on investor relations and S-1 narrative.
- hiringA hiring dinner targeting senior ML and clinical AI engineers from Stanford and NVIDIA networks to fuel Commure's AI agent roadmap.
- introsAn angel syndicate happy hour with other YC-founder angels to co-invest in early-stage health tech and AI infrastructure deals.
- wellbeingA small wellbeing retreat for sub-30 unicorn founders navigating the pressure of rapid company scaling and public scrutiny.